covid-19 vaccine
AssetAlso COVID-19 Vaccine (Vero cell), Inactivated, COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
Inactivated SARS-CoV-2 induces protective immune responses against COVID-19.
- Stage
- Phase 3
- Modality
- Vaccine
- Target
- Not known
- 4
- Indications
- 19
- Trials
- 4
- Developers
Indications
4COVID-19
Phase 3, Completed, NCT05246137, clinicaltrials.gov, 10 Oct 2026
COVID-19 pneumonia
Phase 3, Unknown, NCT05104437, clinicaltrials.gov, 10 Oct 2026
Rabies
Phase 3, Unknown, NCT05453487, clinicaltrials.gov, 10 Oct 2026
1 more
In the full profile
- Owner and partners4
- Trials19
- Evidence for its targets1
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 10 Oct 2026, 9 sources